| Patents for A61P 17 - Drugs for dermatological disorders (106,455) |
|---|
| 12/07/2005 | EP1296639B1 Use of green-light emitting materials in pharmaceutical compositions |
| 12/07/2005 | EP1294711B1 1-(pyrrolidin-1-ylmethyl)-3-(pyrrol-2-ylmethylidene)-2-indolinone derivatives and their use as modulators of protein kinases |
| 12/07/2005 | EP1267806B1 Use of cosmetic and pharmaceutical compositions comprising 2-decarboxy-2-phosphinico derivatives of prostaglandins |
| 12/07/2005 | EP1221852B1 Therapeutic use of antimicrobial compositions comprising a benzoic acid analog and a metal salt |
| 12/07/2005 | EP1216241B1 Carboxylic acids and acylsulfonamides, compositions containing such compounds and methods of treatment |
| 12/07/2005 | EP1196129B1 Pharmaceutical and cosmetic compositions comprising urocanic acid derivatives as radical scavengers or antioxidants |
| 12/07/2005 | EP1178812B1 Methods of making conditioned cell culture medium compositions |
| 12/07/2005 | EP1171442B1 Xanthine derivatives and analogs as cell signalling inhibitors |
| 12/07/2005 | EP1163249B1 Bioprecursors of a retinoic derivative and pharmaceutical and/or cosmetic compositions |
| 12/07/2005 | EP1147089B1 Phenylphenanthridines with pde-iv inhibiting activity |
| 12/07/2005 | EP1019514B1 A keratinocyte derived protease |
| 12/07/2005 | EP1014967B1 Use of zinc salts of conjugated linoleic acids to treat skin disorders |
| 12/07/2005 | EP0981523B1 Cyclic ether vitamin d3 compounds, 1alpha (oh) 3-epi-vitamin d3 compounds and uses thereof |
| 12/07/2005 | EP0922105B1 Infectious papillomavirus pseudoviral particles |
| 12/07/2005 | EP0738328B1 Composition containing nucleic acids, preparation and uses |
| 12/07/2005 | CN1704404A Tricyclic protein kinase inhibitors |
| 12/07/2005 | CN1230434C Indazolyl-substituted pyrroline compounds as kinase inhibitor |
| 12/07/2005 | CN1230433C Cyclic AMP-specific phosphodiesterase inhibitors |
| 12/07/2005 | CN1230431C Arylmethylamine derivatives for use as tryptase inhibitors |
| 12/07/2005 | CN1230206C Polymer blends as biodegradable matrices for preparing biocomposites |
| 12/07/2005 | CN1230200C Stable enzymatic wound debrider |
| 12/07/2005 | CN1230188C Liquid preparation for external application for broad-spectrum sterilization and resisting herpes simplex virus |
| 12/07/2005 | CN1230180C External medicine for killing and inhibiting fungus |
| 12/07/2005 | CN1230169C Use of cyclopamine in the treatment of psoriasis |
| 12/07/2005 | CN1230166C Gyrase inhibitors and uses thereof |
| 12/07/2005 | CN1230148C Composition containing N-vinyl iminazole polymer or copolymer and oxidation sensitive hydrophilic active ingredients for cosmetics and/or dermatology |
| 12/06/2005 | US6972321 Monomeric protein of the TGF-β family |
| 12/06/2005 | US6972295 Central nervous system disorders; psychological disorders; antiinflammatory agents; multiple sclerosis |
| 12/06/2005 | CA2347512C Adenine derivatives |
| 12/06/2005 | CA2272745C 2-alkyl-19-nor-vitamin d compounds |
| 12/01/2005 | WO2005113534A2 Cxcr1 and cxcr2 chemokine antagonists |
| 12/01/2005 | WO2005112950A1 Spinosyns for wound healing |
| 12/01/2005 | WO2005112948A1 Drug for remedy or treatment of wound |
| 12/01/2005 | WO2005112877A1 Scalp and hair-care composition |
| 12/01/2005 | US20050267304 Protein kinase inhibitors; astham; psoriasis; antiinflammatory agents; inflammatory bowel disorders |
| 12/01/2005 | US20050267205 2,4-dihydroxybenzoic acid derivatives |
| 12/01/2005 | US20050267204 Synergistic gold-containing compositions |
| 12/01/2005 | US20050267196 Reducing tumor necrosis factor; phosphodiesterase inhibitor; anticancer agents; antidepressants; antiinflammatory agents; skin dsorders; antidepressants |
| 12/01/2005 | US20050267190 Solid-state form of celecoxib having enhanced bioavailability |
| 12/01/2005 | US20050267189 Celecoxib compositions |
| 12/01/2005 | US20050267185 1,2,4-triazole derivatives, compositions, process of making and methods of use |
| 12/01/2005 | US20050267165 Il-8 receptor antagonists |
| 12/01/2005 | US20050267163 Vanilloid receptor ligands and their use in treatments |
| 12/01/2005 | US20050267137 Cyclopropane CGRP antagonists, medicaments containing these compounds, and method for the production thereof |
| 12/01/2005 | US20050267133 Pyrazolopyrimidines as kinase inhibitors |
| 12/01/2005 | US20050267114 Triazaspiro[5.5]undecane derivatives and drugs comprising the same as the active ingredient |
| 12/01/2005 | US20050267081 Use of a combination of ethinyloestradiol and chlormadinone acetate to produce a pharmaceutical preparation |
| 12/01/2005 | US20050267064 Containing unmethylated CpG dinucleotides, and an allergen; desensitization |
| 12/01/2005 | US20050267062 Endothelial growth factors; antiischemic agents; neovascularization |
| 12/01/2005 | US20050267057 Redirect a Th2 response to a Th1 response; treating asthma, allergies, infections, cancer immunotherapy; contain unmethylated cytosine-guanine (CpG) dinucleotides |
| 12/01/2005 | US20050267024 Polypeptide, cancer therapy, neovascularization defects, retinopathies, arthritis and psoraisis |
| 12/01/2005 | US20050266533 Therapeutic fusion protein with enhanced for use in prevention and treatment of cell proliferative, blood and nervous system disorders |
| 12/01/2005 | US20050266532 Albumin fusion proteins |
| 12/01/2005 | US20050266098 Composition for treatment of a hydrofluoric acid burn |
| 12/01/2005 | US20050266065 Hydrated lamellar phases or liposomes which contain a fatty monoamine or a cationic polymer which promotes intracellular penetration, and a cosmetic or pharmaceutical composition containing same, as well as a method of screening such a substance |
| 12/01/2005 | US20050266035 Skin protectant spray compositions |
| 12/01/2005 | US20050266002 Methods for the treatment of cancer using anti-CD40 antibodies |
| 12/01/2005 | US20050265986 Sphingomyelinase compositions and use thereof |
| 12/01/2005 | US20050265976 Method of differentiation of morula or inner cell mass cells and method of making lineage-defective embryonic stem cells |
| 12/01/2005 | US20050265965 Modified cytokines for use in cancer therapy |
| 12/01/2005 | US20050265944 Carbohydrate-based anti-wrinkle and tissue remodelling compounds |
| 12/01/2005 | DE102004023612A1 Use of microbial mixed biocoenosis comprising photosynthetic bacteria, actinomycete, lactic acid bacteria, yeast or ferment active fungus, for treating skin inflammations and dermatitis |
| 12/01/2005 | DE102004022383A1 New pyridopyrazine derivatives are modulators of kinase activity, useful for the treatment of diseases associated with abnormal cellular signaling, e.g. tumors |
| 12/01/2005 | CA2566713A1 Wound healing polymer compositions and methods for use thereof |
| 12/01/2005 | CA2565519A1 Cxcr1 and cxcr2 chemokine antagonists |
| 12/01/2005 | CA2551613A1 A composition comprising n-acetyl-d-glucosamine for treatment of wound |
| 11/30/2005 | EP1600501A1 Use of lif for tissue and cellular engineering |
| 11/30/2005 | EP1600453A1 Compound, process for producing the same and use thereof |
| 11/30/2005 | EP1600440A1 Indole derivative compounds and drugs containing the compounds as the active ingredient |
| 11/30/2005 | EP1600163A1 Use of the neurotoxic component of botulinum toxins for the treatment of spastic muscle |
| 11/30/2005 | EP1600158A1 Use of ondansetron for the treatment of inflammation, and pharmaceutical compositions thereof |
| 11/30/2005 | EP1600152A1 Use of LIF in cosmetics and dermatology |
| 11/30/2005 | EP1599482A1 Pyrazolo 1,5-a pyrimidine derivatives |
| 11/30/2005 | EP1599464A2 Novel cyclic urea derivatives, preparation method thereof and pharmaceutical use of same as kinase inhibitors |
| 11/30/2005 | EP1599447A1 Ligands that modulate lxr-type receptors |
| 11/30/2005 | EP1599219A1 Treatment of chronic chalazion and hordeolum with botulinum toxin |
| 11/30/2005 | EP1599175A2 Imidazopyridines containing combinations and their use in treating gastrointestinal inflammatory disorders |
| 11/30/2005 | EP1317483B1 Variants of allergenic proteins of the group 2 of dermatophagoides |
| 11/30/2005 | EP1289537B1 Method of treating chronic ulcers |
| 11/30/2005 | EP1289534B1 Apoptotic entities for use in treatment of t-cell-mediated and inflammatory disorders |
| 11/30/2005 | EP1227794B1 Method for encapsulating proteins or peptides in liposomes |
| 11/30/2005 | EP1176981B1 Treatment of autoimmune diseases with antagonists which bind to b cell surface markers |
| 11/30/2005 | EP1144372B1 Sulphohydroxamic acids and sulphohydroxamates and their use as mek inhibitors |
| 11/30/2005 | EP1140010B1 Composition and method of sequestration of skin irritants. |
| 11/30/2005 | EP1109909B1 Grf analogs with increased biological potency |
| 11/30/2005 | EP1091943B1 Non-peptidyl inhibitors of vla-4 dependent cell binding useful in treating inflammatory, autoimmune, and respiratory diseases |
| 11/30/2005 | CN1703420A Promoters exhibiting endothelial cell specificity and methods of using same |
| 11/30/2005 | CN1703405A Aminobenzamide derivatives as glycogen synthase kinase 3 beta inhibitors |
| 11/30/2005 | CN1703234A The use of low-molecular-weight thrombin inhibitor |
| 11/30/2005 | CN1701792A Preparation for external use on skin |
| 11/30/2005 | CN1701791A Medicine for treating allergic skin disease and its preparation process |
| 11/30/2005 | CN1229381C Macrolides compound |
| 11/30/2005 | CN1229375C Nicotinic acetylcholine receptor inhibitor, its prepn. and application |
| 11/30/2005 | CN1229373C Piperidinee derivatives as neurokinin1 antagonists |
| 11/30/2005 | CN1229351C Heterocyclic compounds and methods to treat cardiac failure and other disorders |
| 11/30/2005 | CN1229349C Pyridine-3-carboxylic acid derivative |
| 11/30/2005 | CN1229343C Chemotactic factor receptor active regulator |
| 11/30/2005 | CN1229335C Nervinolin derivatives |
| 11/30/2005 | CN1229331C Inhibitor of monoamine uptake |
| 11/30/2005 | CN1229123C Medicinal plaster for treating burn and scald |